EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Triptolide Ameliorates Allergic Rhinitis and Is Associated With Suppression of the p38 MAPK Pathway: A Network Pharmacology and Experimental Study

Binbin Shi iD, Qingjun Yang, Feiyu Wang, Jijun Song, Youwei Bao iD

Immunity, Inflammation and Disease · 2026-11 · 14 (11)

DOI: 10.1002/iid3.70552 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 17.11.2026. Verfasst von Binbin Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Zhoukou Central Hospital, Zhoukou, Henan, China. Hauptthemen laut MEDLINE: Diterpenes, Phenanthrenes, Rhinitis, Allergic, p38 Mitogen-Activated Protein Kinases. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhoukou Key Scientific Research and Technological Breakthrough Project, Zhoukou Central Hospital-Level Project (Doctoral Research Startup Fund).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Allergic rhinitis (AR) is a global disease characterized by Th2 inflammation and eosinophil infiltration. Triptolide (TP), the main active component of Tripterygium wilfordii, has significant anti‐inflammatory effects, but its multi‐target mechanism for treating AR remains unclear.

Objective

To analyze the mechanism of TP against AR through network pharmacology prediction and experimental validation.

Methods

Core targets and pathways of TP were screened using network pharmacology. A house dust mite (HDM)‐induced AR mouse model (BALB/c, n = 6/group) was established and treated with TP (10/20/30 μg/kg) or dexamethasone (2 mg/kg). Serum levels of IL‐4, IL‐5, IL‐13, and IgE were detected by ELISA. Pathological changes in nasal and lung tissues were assessed by HE staining. P38 MAPK, p‐p38 MAPK, PTGS2, and VCAM‐1 were analyzed by Western blot (WB) and qPCR. In vitro experiments used HDM‐stimulated human nasal epithelial cells (HNEPCs) to evaluate inflammatory markers.

Results

Network analysis identified 33 shared targets, including MAPK14, MAPK1, NFKB1, PTGS2, and VCAM1, which were enriched in MAPK, TNF, NF‐κB, and IL‐17 signaling pathways. In vivo experiments showed that TP (20 µg/kg) significantly reduced IgE and Th2 cytokine levels, inhibited eosinophil infiltration, and was associated with suppressed p38 MAPK phosphorylation.

Conclusion

TP alleviates Th2 inflammation and immune imbalance, and these effects are associated with suppression of the p38 MAPK signaling pathway and downstream PTGS2/VCAM‐1. Whether TP can serve as an alternative treatment strategy for steroid‐dependent AR requires further validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiterpenesPhenanthrenesRhinitis, Allergicp38 Mitogen-Activated Protein KinasesAnti-Inflammatory AgentsMAP Kinase Signaling SystemAnimalsEpoxy CompoundsHumansMiceNetwork PharmacologyDisease Models, AnimalMice, Inbred BALB CCytokinesNasal Mucosa

Stichwörter der Autor:innen

P38 MAPK pathwayTh2 inflammationallergic rhinitisnetwork pharmacologytriptolide

Substanzen

triptolideDiterpenesEpoxy CompoundsPhenanthrenesp38 Mitogen-Activated Protein KinasesCytokinesAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Zhoukou Central Hospital, Zhoukou, Henan, China.
  • Henan Provincial Key Laboratory of Viral Molecular Biology, Zhoukou, Henan, China.
  • Zhoukou Municipal Medical Science Research Center, Zhoukou, Henan, China.
  • Public Laboratory Center of Zhoukou Central Hospital, Zhoukou, Henan, China.

ORCID-Profile: Binbin Shi, Youwei Bao

Förderung

  • Zhoukou Key Scientific Research and Technological Breakthrough Project
  • Zhoukou Central Hospital-Level Project (Doctoral Research Startup Fund)

Zitieren

APA

Shi, B., Yang, Q., Wang, F., Song, J., & Bao, Y. (2026). Triptolide Ameliorates Allergic Rhinitis and Is Associated With Suppression of the p38 MAPK Pathway: A Network Pharmacology and Experimental Study. Immunity, Inflammation and Disease, 14(11). https://doi.org/10.1002/iid3.70552

Vancouver

Shi B, Yang Q, Wang F, Song J, Bao Y. Triptolide Ameliorates Allergic Rhinitis and Is Associated With Suppression of the p38 MAPK Pathway: A Network Pharmacology and Experimental Study. Immunity, Inflammation and Disease. 2026;14(11). doi:10.1002/iid3.70552

BibTeX
@article{Shi2026,
  author = {Shi, Binbin and Yang, Qingjun and Wang, Feiyu and Song, Jijun and Bao, Youwei},
  title = {Triptolide Ameliorates Allergic Rhinitis and Is Associated With Suppression of the p38 MAPK Pathway: A Network Pharmacology and Experimental Study},
  journal = {Immunity, Inflammation and Disease},
  year = {2026},
  volume = {14},
  number = {11},
  doi = {10.1002/iid3.70552}
}
Kostenlos starten →